Compare SMX & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SMX | OSRH |
|---|---|---|
| Founded | N/A | N/A |
| Country | Ireland | United States |
| Employees | 19 | 22 |
| Industry | Industrial Machinery/Components | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.7M | 17.9M |
| IPO Year | N/A | N/A |
| Metric | SMX | OSRH |
|---|---|---|
| Price | $13.76 | $0.37 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 111.0K | ★ 928.1K |
| Earning Date | 04-23-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.75 | $0.37 |
| 52 Week High | $490.00 | $1.57 |
| Indicator | SMX | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 56.73 | 36.50 |
| Support Level | $7.19 | N/A |
| Resistance Level | $20.06 | $0.45 |
| Average True Range (ATR) | 2.11 | 0.03 |
| MACD | -0.14 | 0.00 |
| Stochastic Oscillator | 23.36 | 5.68 |
SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. The company's pipeline products include: Vaximm, Darnatein, Woori IO, and RMC.